Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Shares Issued (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Shares Issued for 3 consecutive years, with $7.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued rose 817.74% to $7.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.1 million, a 126.81% increase, with the full-year FY2025 number at $10.1 million, up 126.81% from a year prior.
  • Shares Issued was $7.7 million for Q4 2025 at Nuvation Bio, up from $558000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $7.7 million in Q4 2025 to a low of $21000.0 in Q1 2024.
  • A 3-year average of $1.5 million and a median of $801000.0 in 2024 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: crashed 92.95% in 2024, then skyrocketed 5052.38% in 2025.
  • Nuvation Bio's Shares Issued stood at $77000.0 in 2023, then soared by 990.91% to $840000.0 in 2024, then surged by 817.74% to $7.7 million in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Shares Issued are $7.7 million (Q4 2025), $558000.0 (Q3 2025), and $762000.0 (Q2 2025).